Psoriasis is a chronic immune-related skin disease, characterized by patches of thick, red or pink skin covered with silvery-white scales^[1]. These scaly patches (called plaques) often itch or burn. Psoriasis most commonly appears on the elbows and knees, but it can affect many areas – the scalp is frequently involved, and plaques can also show up on the lower back or even in body folds like the groin^[2].

The appearance of psoriasis can vary: on lighter skin it tends to look red with white scale, whereas on darker skin it may appear purplish or brownish with gray scale. Psoriasis plaques are not contagious, but they can be embarrassing or uncomfortable, sometimes cracking and bleeding. The disease typically runs a long-term course with periods of flare-ups and remissions.

Psoriasis is not just skin deep. It has a number of important comorbidities (associated health conditions) that patients and doctors should watch for. For instance, about 1 in 3 people with psoriasis will develop psoriatic arthritis, an inflammatory joint condition that causes joint pain and swelling. Psoriasis is also linked to a higher risk of cardiovascular disease (heart attacks and strokes) and metabolic syndrome (conditions like obesity and type 2 diabetes)^[3]. Other conditions associated with psoriasis include Crohn’s disease (an inflammatory bowel disease) and even an increased risk of depression^[3].

Because of these connections, comprehensive care for psoriasis includes screening for these comorbidities – we know psoriasis affects the body as a whole, not just the skin. In our clinical trials and practice, we pay close attention to these related health issues and help patients get the care they need for any underlying problems. This thorough approach “unmasks” hidden issues and reinforces that psoriasis, too, is more than a skin-deep condition.

The outlook for psoriasis patients continues to improve as research progresses. There is no cure yet, but many effective treatments exist – topical creams, phototherapy (light treatments), and powerful newer drugs that calm the immune system’s overactivity. In recent years, biologic medications (injections or infusions targeting specific immune molecules) have dramatically improved psoriasis for many patients.

Now, research is bringing even more options, including oral treatments that can achieve similar results. By participating in a psoriasis clinical trial, you can gain access to the latest treatments years before they become standard^[4]. These investigational therapies might offer easier dosing (for example, a pill instead of an injection) or fewer side effects, all while maintaining or improving effectiveness.

Not only do trial participants potentially benefit from these cutting-edge medications, but they also contribute to advancing medical knowledge – helping to shape a future where managing psoriasis (and its related conditions) is even safer and easier for everyone.

Sources:
[1] [2] [3] Psoriasis - Wikipedia
[4] Cancer Clinical Trials | UNM Cancer Center